These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6297678)

  • 1. Activation of dopamine-containing amacrine cells of retina: light-induced increase of acidic dopamine metabolites.
    Cohen J; Hadjiconstantinou M; Neff NH
    Brain Res; 1983 Jan; 260(1):125-7. PubMed ID: 6297678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons.
    Melamed E; Durst R; Frucht Y; Globus M
    Eur J Pharmacol; 1983 May; 89(3-4):279-82. PubMed ID: 6873163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine.
    Agut J; Coviella IL; Wurtman RJ
    Neuropharmacology; 1984 Dec; 23(12A):1403-6. PubMed ID: 6543245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol inhibits the disappearance of acidic dopamine metabolites from rat striatum.
    Moleman P; Bruinvels J; van Valkenburg CF
    J Pharm Pharmacol; 1978 Sep; 30(9):583-5. PubMed ID: 29101
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis.
    Zetterström T; Ungerstedt U
    Eur J Pharmacol; 1984 Jan; 97(1-2):29-36. PubMed ID: 6199219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance develops to the haloperidol-induced increase in the efflux of dopamine metabolites from the brains of unanesthetized, freely-moving rats.
    Nielsen JA; Duda NJ; Moore KE
    Life Sci; 1982 Oct; 31(14):1495-1500. PubMed ID: 6183554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine metabolites and catalepsy after lithium and haloperidol.
    Bowers MB; Rozitis A
    Eur J Pharmacol; 1982 Feb; 78(1):113-5. PubMed ID: 7200429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum.
    Tanganelli S; von Euler G; Fuxe K; Agnati LF; Ungerstedt U
    Brain Res; 1989 Nov; 502(2):319-24. PubMed ID: 2819469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion.
    Salamone JD; Keller RW; Zigmond MJ; Stricker EM
    Brain Res; 1989 May; 487(2):215-24. PubMed ID: 2786443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choline and physostigmine enhance haloperidol-induced HVA and DOPAC accumulation.
    Millington WR; Wurtman RJ
    Eur J Pharmacol; 1982 Jun; 80(4):431-4. PubMed ID: 7106193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of subchronic haloperidol and sulpiride on regional brain dopamine metabolism in the rat.
    Lindefors N; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1986 Oct; 129(3):401-4. PubMed ID: 3780852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of low versus high doses of apomorphine on retinal dopamine metabolism in light- and dark-adapted rabbits.
    Drumheller A; Henni H; Lafond G; Brunette JR; Jolicoeur FB
    Pharmacol Biochem Behav; 1995 Jan; 50(1):83-90. PubMed ID: 7700958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine loading increases dopamine metabolite concentrations in the brain.
    Chance WT; Foley-Nelson T; Nelson JL; Fischer JE
    Pharmacol Biochem Behav; 1990 Jan; 35(1):195-9. PubMed ID: 2315359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apomorphine- and haloperidol-induced change in 3,4-dihydroxyphenylacetic acid content in the mesolimbic-striatum of the developing rat.
    Nomura Y; Oki K; Segawa T
    J Pharmacobiodyn; 1980 Feb; 3(2):111-6. PubMed ID: 7205536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine administration enhances dopamine synthesis and release in light-activated rat retina.
    Gibson CJ; Watkins CJ; Wurtman RJ
    J Neural Transm; 1983; 56(2-3):153-60. PubMed ID: 6134783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhythmic changes in metabolism of dopamine in the chick retina: the importance of light versus biological clock.
    Zawilska JB; Bednarek A; Berezińska M; Nowak JZ
    J Neurochem; 2003 Feb; 84(4):717-24. PubMed ID: 12562516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment.
    Barkai AI; Kowalik S; Reches A
    Psychopharmacology (Berl); 1984; 84(3):352-5. PubMed ID: 6083575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.